TYRA
Tyra Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.07
−1.91%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-42.0%
Return on equity
-38.8%
Return on assets
-44.7%
Return on invested capital
0.00x
Asset turnover
-$109.7M
Cash from operations
$5.15
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026